Showing results (101-110 of 182) with videos related to
Sort By:
Pageof 19
NPJ Digital Medicine|July 16, 2019
The Healthy Pregnancy Research Program: transforming pregnancy research through a ResearchKit appJennifer M Radin, Steven R Steinhubl, Andrew I Su, et al.The American Journal of Cardiology|May 10, 2005
Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trialsVictor L Serebruany, Steven R Steinhubl, Peter B Berger, et al.Thrombosis Research|October 24, 2007
Platelet activation and its patient-specific consequencesSusan S Smyth, Dougald M Monroe, Waldemar E Wysokinski, et al.The Journal of Invasive Cardiology|September 7, 2006
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularizationPranab Das, David J Moliterno, Richard Charnigo, et al.Journal of Osteopathic Medicine|September 30, 2021
C-reactive protein levels associated with COVID-19 outcomes in the United StatesJacob Lentner, Taylor Adams, Valene Knutson, et al.Archives of Internal Medicine|December 12, 2007
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trialsRaphaelle Dumaine, Maria Borentain, Osmund Bertel, et al.Stroke|September 9, 2006
Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarctionEric Van de Graaff, Monisha Dutta, Pranab Das, et al.American Heart Journal|December 19, 2006
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudyW H Wilson Tang, Steven R Steinhubl, Frederick Van Lente, et al.Nature Medicine|October 30, 2020
Wearable sensor data and self-reported symptoms for COVID-19 detectionGiorgio Quer, Jennifer M Radin, Matteo Gadaleta, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2007
Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophilsGuohong Li, Alison C Keenan, Justin C Young, et al.Pageof 19